| abstract |
Disclosed are new triazoloquinazolines having the formula (I), in which A, X, R1 and R2 have the meaning given in the description, as well as their production. These compounds (I) are suitable as active substances for human and veterinary medicaments and may be used for producing drugs for treating neurodegener-ative diseases and neurotoxic disorders of the central nervous system, as well as for prepar-ing spasmolytic, anti-epiletic, anxiolytic and anti-depressive drugs. |